A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients

Medical Physics

Volumn 36, Issue 3, 2009, Pages 776-787

  Butler, Wayne M ^a   Stewart, Renee R ^a   Merrick, Gregory S ^a  

^a NONE

Author keywords

BED; Brachytherapy; DVH; EUD; Prostate; Radiobiology; TCP

Indexed keywords

LOGISTIC REGRESSION; ONCOLOGY; RADIOTHERAPY; TRANSMISSION CONTROL PROTOCOL; UROLOGY;

BRACHYTHERAPY; CONDITIONAL LOGISTIC REGRESSIONS; EQUIVALENT UNIFORM DOSE; PROSTATE; PROSTATE BRACHYTHERAPY; RADIOBIOLOGICAL PARAMETERS; RADIOBIOLOGY; TUMOR CONTROL PROBABILITY;

DOSIMETRY;

IODINE 125; PALLADIUM 103;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CALCULATION; CANCER CONTROL; CASE CONTROL STUDY; CONTROLLED STUDY; DOSE VOLUME HISTOGRAM; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HISTOGRAM; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIOBIOLOGY; TREATMENT FAILURE;

EID: 61349196765     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3077161     Document Type: Article

References (39)

1. R. G. Stock, N. N. Stone, A. Tabert, C. Iannuzzi and J. K. DeWyngaert, " A dose-response study for I-125 prostate implants.," Int. J. Radiat. Oncol., Biol., Phys. 41, 101-108 (1998).
2. L. Potters, Y. Cao, E. Calugaru, T. Torre, P. Fearn, and X. H. Wang, " A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 50, 605-614 (2001).
3. N. N. Stone, L. Potters, B. J. Davis, J. P. Ciezki, M. J. Zelefsky, M. Roach, P. A. Fearn, M. W. Kattan, and R. G. Stock, " Customized dose prescription for permanent prostate brachytherapy: Insights from a multicenter analysis of dosimetry outcomes.," Int. J. Radiat. Oncol., Biol., Phys. 69, 1472-1477 (2007).
4. G. S. Merrick, W. M. Butler, K. E. Wallner, J. C. Blasko, J. Michalski, J. Aronowitz, P. Grimm, B. J. Moran, P. W. McLaughlin, J. Usher, J. H. Lief, and Z. A. Allen, " Variability of prostate brachytherapy pre-implant dosimetry: A multi-institutional analysis.," Brachytherapy 4, 241-251 (2005).
5. W. D. D'Souza, H. D. Thames, and D. A. Kuban, " Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.," Int. J. Radiat. Oncol., Biol., Phys. 58, 1540-1548 (2004).
6. R. Nath, W. Bice, W. M. Butler, Z. Chen, A. S. Meigooni, V. Narayana, M. J. Rivard, and Y. Yu, " AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: The report of Task Group 137.," Med. Phys. (submitted).
7. N. Bittner, G. S. Merrick, R. W. Galbreath, W. M. Butler, K. E. Wallner, Z. A. Allen, S. G. Brammer, and M. Moyad, " Primary causes of death after permanent prostate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 72, 433-440 (2008).
8. J. Z. Wang, M. Guerrero, and X. A. Li, " How low is the alpha/beta ratio for prostate cancer?," Int. J. Radiat. Oncol., Biol., Phys. 55, 194-203 (2003).
9. J. Z. Wang and X. A. Li, " Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose.," Med. Phys. 30, 34-40 (2003).
10. J. Z. Wang, N. A. Mayr, S. Nag, J. Montebello, N. Gupta, N. Samsami, and C. Kanellitsas, " Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.," Med. Phys. 33, 1025-1032 (2006).
11. R. G. Stock, N. N. Stone, J. A. Cesaretti, and B. S. Rosenstein, " Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.," Int. J. Radiat. Oncol., Biol., Phys. 64, 527-533 (2006).
12. Y. Yu, " A nondivergent specification of the mean treatment dose in interstitial brachytherapy.," Med. Phys. 23, 905-909 (1996).
13. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, " Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose.," Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002).
14. W. M. Butler, G. S. Merrick, J. H. Lief, and A. T. Dorsey, " Comparison of seed loading approaches in prostate brachytherapy.," Med. Phys. 27, 381-392 (2000).
15. G. S. Merrick and W. M. Butler, " Modified uniform seed loading for prostate brachytherapy: Rationale, design, and evaluation.," Tech. Urol. 6, 78-84 (2000).
16. G. S. Merrick, W. M. Butler, K. E. Wallner, R. W. Galbreath, and E. Adamovich, " Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.," W. Va. Med. J. 101, 168-171 (2005).
17. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 31, 633-674 (2004).
18. J. F. Williamson, W. Butler, L. A. Dewerd, M. S. Huq, G. S. Ibbott, M. G. Mitch, R. Nath, M. J. Rivard, and D. Todor, " Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy.," Med. Phys. 32, 1424-1439 (2005).
19. J. F. Fowler, " The linear-quadratic formula and progress in fractionated radiotherapy.," Br. J. Radiol. 62, 679-694 (1989).
20. R. G. Dale, " The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.," Br. J. Radiol. 58, 515-528 (1985).
21. R. G. Dale, " Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model.," Br. J. Radiol. 62, 241-244 (1989).
22. R. G. Dale and B. Jones, " The clinical radiobiology of brachytherapy.," Br. J. Radiol. 71, 465-483 (1998).
23. M. A. Moerland, R. van der Laarse, R. W. Luthmann, H. K. Wijrdeman, and J. J. Battermann, " The combined use of the natural and the cumulative dose-volume histograms in planning and evaluation of permanent prostatic seed implants.," Radiother. Oncol. 57, 279-284 (2000).
24. L. L. Anderson, " A natural volume-dose histogram for brachytherapy.," Med. Phys. 13, 898-903 (1986).
25. S. Choi, K. E. Wallner, G. S. Merrick, W. Cavanagh, and W. M. Butler, " Treatment margins predict biochemical outcomes after prostate brachytherapy.," Cancer J. 10, 175-180 (2004).
26. P. Orio, K. Wallner, G. Merrick, A. Herstein, P. Mitsuyama, K. Thornton, W. Butler, and S. Sutlief, " Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation.," Int. J. Radiat. Oncol., Biol., Phys. 67, 342-346 (2007).
27. C. R. King, T. A. DiPetrillo, and D. E. Wazer, " Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.," Int. J. Radiat. Oncol., Biol., Phys. 46, 165-172 (2000).
28. R. Singh, H. Al-Hallaq, C. A. Pelizzari, G. P. Zagaja, A. Chen, and A. B. Jani, " Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose.," Med. Dosim. 28, 255-259 (2003).
29. A. B. Jani, C. M. Hand, A. E. Lujan, J. C. Roeske, G. P. Zagaja, S. Vijayakumar, and C. A. Pelizzari, " Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans.," Med. Dosim. 29, 42-48 (2004).
30. C. C. Ling, J. Roy, N. Sahoo, K. Wallner, and L. Anderson, " Quantifying the effect of dose inhomogeneity in brachytherapy: application to permanent prostatic implant with 125I seeds.," Int. J. Radiat. Oncol., Biol., Phys. 28, 971-978 (1994).
31. A. Haworth, M. Ebert, D. Waterhouse, D. Joseph, and G. Duchesne, " Prostate implant evaluation using tumour control probability - the effect of input parameters.," Phys. Med. Biol. 49, 3649-3664 (2004).
32. G. S. Merrick, W. M. Butler, K. E. Wallner, L. R. Burden, and J. E. Dougherty, " Extracapsular radiation dose distribution after permanent prostate brachytherapy.," Am. J. Clin. Oncol. 26, e178-e189 (2003).
33. E. F. Miles, J. W. Nelson, A. K. Alkaissi, S. Das, R. W. Clough, M. S. Anscher, and J. R. Oleson, " Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer.," Brachytherapy 7, 206-211 (2008).
34. H. A. Gay and A. Niemierko, " A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.," Phys. Medica 23, 115-125 (2007).
35. G. S. Merrick, W. M. Butler, A. T. Dorsey, and J. H. Lief, " Potential role of various dosimetric quality indicators in prostate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 44, 717-724 (1999).
36. G. S. Merrick, W. M. Butler, A. T. Dorsey, and H. L. Walbert, " Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.," Radiat. Oncol. Invest. 6, 182-190 (1998).
37. Z. Chen, N. Yue, X. Wang, K. B. Roberts, R. Peschel, and R. Nath, " Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.," Int. J. Radiat. Oncol., Biol., Phys. 47, 1405-1419 (2000).
38. G. S. Merrick, W. M. Butler, A. T. Dorsey, and J. H. Lief, " The dependence of prostate postimplant dosimetric quality on CT volume determination.," Int. J. Radiat. Oncol., Biol., Phys. 44, 1111-1117 (1999).
39. X. A. Li, J. Z. Wang, R. D. Stewart, and S. J. DiBiase, " Dose escalation in permanent brachytherapy for prostate cancer: Dosimetric and biological considerations.," Phys. Med. Biol. 48, 2753-2765 (2003).